{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:09:50Z","timestamp":1780441790131,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04819-4","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:12:46Z","timestamp":1776697966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["hsa_circ_0068631 facilitates the progression of diabetic retinopathy via regulating miR-140-5p in retinal microvascular endothelial cells"],"prefix":"10.1186","volume":"26","author":[{"given":"Bo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"6","key":"4819_CR1","doi-asserted-by":"publisher","first-page":"e201023222418","DOI":"10.2174\/0115733998253672231011161400","volume":"20","author":"V Kour","year":"2024","unstructured":"Kour V, Swain J, Singh J, Singh H, Kour H. A Review on Diabetic Retinopathy. Curr Diabetes Rev. 2024;20(6):e201023222418.","journal-title":"Curr Diabetes Rev"},{"key":"4819_CR2","doi-asserted-by":"publisher","first-page":"1077669","DOI":"10.3389\/fendo.2022.1077669","volume":"13","author":"TE Tan","year":"2022","unstructured":"Tan TE, Wong TY. Diabetic retinopathy: Looking forward to 2030. Front Endocrinol. 2022;13:1077669.","journal-title":"Front Endocrinol"},{"issue":"8","key":"4819_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3949\/ccjm.91a.24028","volume":"91","author":"DD Chong","year":"2024","unstructured":"Chong DD, Das N, Singh RP. Diabetic retinopathy: Screening, prevention, and treatment. Cleve Clin J Med. 2024;91(8):503\u201310.","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"4819_CR4","doi-asserted-by":"publisher","first-page":"21249","DOI":"10.1002\/jcp.28730","volume":"234","author":"B Chen","year":"2019","unstructured":"Chen B, Li Y, Liu Y, Xu Z. circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell Physiol. 2019;234(11):21249\u201359.","journal-title":"J Cell Physiol"},{"issue":"21","key":"4819_CR5","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.21037\/atm-21-5562","volume":"9","author":"J Shao","year":"2021","unstructured":"Shao J, Cai J, Yao Y, Zhu H. Hyperglycemia-induced increasing of RELB\/circ_0008590 in NF-\u03baB pathway is repressed by miR-1243 in human retinal microvascular endothelial cells. Annals translational Med. 2021;9(21):1624.","journal-title":"Annals translational Med"},{"key":"4819_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","volume":"348","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang Y, Zhou S, Dain L, Mei L, Zhu G, Circular RNA. An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J controlled release: official J Controlled Release Soc. 2022;348:84\u201394.","journal-title":"J controlled release: official J Controlled Release Soc"},{"key":"4819_CR7","doi-asserted-by":"publisher","first-page":"148941","DOI":"10.1016\/j.gene.2024.148941","volume":"933","author":"D Yifan","year":"2025","unstructured":"Yifan D, Jiaheng Z, Yili X, Junxia D, Chao T. CircRNA: A new target for ischemic stroke. Gene. 2025;933:148941.","journal-title":"Gene"},{"key":"4819_CR8","doi-asserted-by":"crossref","unstructured":"Luo Q, Hajrasouliha AR, Bhatwadekar AD. miR-92a and integrin expression in fibrovascular membranes in proliferative diabetic retinopathy. Front Ophthalmol. 2023;3.","DOI":"10.3389\/fopht.2023.1116838"},{"issue":"2","key":"4819_CR9","doi-asserted-by":"publisher","first-page":"112291","DOI":"10.1016\/j.yexcr.2020.112291","volume":"396","author":"J Wang","year":"2020","unstructured":"Wang J, Lin Z, Yang Z, Liu X. lncRNA Eif4g2 improves palmitate-induced dysfunction of mouse \u03b2-cells via modulation of Nrf2 activation. Exp Cell Res. 2020;396(2):112291.","journal-title":"Exp Cell Res"},{"issue":"2","key":"4819_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12272-021-01308-8","volume":"44","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Song C, Wang T, Sun L, Qin L, Ju J. miR-139-5p promotes neovascularization in diabetic retinopathy by regulating the phosphatase and tensin homolog. Arch Pharm Res. 2021;44(2):205\u201318.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"4819_CR11","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/03635465221073991","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zeng Y, Si HB, Tang L, Xie HQ, Shen B. Exosomes Derived From Human Urine-Derived Stem Cells Overexpressing miR-140-5p Alleviate Knee Osteoarthritis Through Downregulation of VEGFA in a Rat Model. Am J Sports Med. 2022;50(4):1088\u2013105.","journal-title":"Am J Sports Med"},{"key":"4819_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","volume":"15","author":"L Zhao","year":"2018","unstructured":"Zhao L, Qi Y, Xu L, Tao X, Han X, Yin L, et al. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biol. 2018;15:284\u201396.","journal-title":"Redox Biol"},{"key":"4819_CR13","doi-asserted-by":"crossref","unstructured":"Luo Y, Li Y, Peng H, Zhao Y. miR-140-5p regulates vascular smooth muscle cell viability, migration and apoptosis by targeting ROBO4 gene expression in atherosclerosis. Mol Med Rep. 2021;23(3).","DOI":"10.3892\/mmr.2021.11852"},{"key":"4819_CR14","doi-asserted-by":"crossref","unstructured":"Su J, Ren J, Chen H, Liu B. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4\/NF-\u03baB signaling pathway in human renal tubular epithelial cells. Biosci Rep. 2020;40(3).","DOI":"10.1042\/BSR20192384"},{"issue":"1","key":"4819_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12886-023-03046-5","volume":"23","author":"C Fu","year":"2023","unstructured":"Fu C, Peng J, Ling Y, Zhao H, Zhao Y, Zhang X, et al. Apigenin inhibits angiogenesis in retinal microvascular endothelial cells through regulating of the miR-140-5p\/HDAC3-mediated PTEN\/PI3K\/AKT pathway. BMC Ophthalmol. 2023;23(1):302.","journal-title":"BMC Ophthalmol"},{"key":"4819_CR16","doi-asserted-by":"crossref","unstructured":"Liu M, Liu H, Zhou J, Yu Z. miR\u2013140\u20135p inhibits the proliferation of multiple myeloma cells by targeting VEGFA. Mol Med Rep. 2021;23(1).","DOI":"10.3892\/mmr.2020.11691"},{"issue":"6","key":"4819_CR17","first-page":"535","volume":"6","author":"B Bahrami","year":"2017","unstructured":"Bahrami B, Hong T, Gilles MC, Chang A. Anti-VEGF Therapy for Diabetic Eye Diseases. Asia-Pacific J Ophthalmol (Philadelphia Pa). 2017;6(6):535\u201345.","journal-title":"Asia-Pacific J Ophthalmol (Philadelphia Pa)"},{"key":"4819_CR18","doi-asserted-by":"crossref","unstructured":"Ji J, Xiong C, Peng J, Zhang N, Zhang Y, Yang H et al. Circ_0068631 sponges miR-139-5p to promote the growth and metastasis of cutaneous squamous cell carcinoma by upregulating HOXB7. Skin Res Technol. official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 2023;29(2):e13248.","DOI":"10.1111\/srt.13248"},{"key":"4819_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.omtn.2021.07.003","volume":"26","author":"X Wang","year":"2021","unstructured":"Wang X, Chen M, Fang L. hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3. Mol therapy Nucleic acids. 2021;26:122\u201334.","journal-title":"Mol therapy Nucleic acids"},{"issue":"1","key":"4819_CR20","doi-asserted-by":"publisher","first-page":"e23049","DOI":"10.1002\/jcla.23049","volume":"34","author":"H Zhang","year":"2020","unstructured":"Zhang H, Shen Y, Li Z, Ruan Y, Li T, Xiao B, et al. The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J Clin Lab Anal. 2020;34(1):e23049.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"4819_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","volume":"29","author":"S Misir","year":"2022","unstructured":"Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs. Cell Death Differ. 2022;29(3):481\u201391.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4819_CR22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1186\/s12967-024-05562-4","volume":"22","author":"J Zhang","year":"2024","unstructured":"Zhang J, Luo Z, Zheng Y, Duan M, Qiu Z, Huang C. CircRNA as an Achilles heel of cancer: characterization, biomarker and therapeutic modalities. J translational Med. 2024;22(1):752.","journal-title":"J translational Med"},{"issue":"1","key":"4819_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41419-025-07759-x","volume":"16","author":"Z Lin","year":"2025","unstructured":"Lin Z, Zhong C, Shi M, Long Q, Jing L, Yu Y, et al. Circular RNA TFRC\/SCD1 mRNA interaction regulates ferroptosis and metastasis in gastric cancer. Cell Death Dis. 2025;16(1):436.","journal-title":"Cell Death Dis"},{"issue":"8","key":"4819_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.63.8.22","volume":"63","author":"H Zhao","year":"2022","unstructured":"Zhao H, Kong H, Wang W, Chen T, Zhang Y, Zhu J, et al. High Glucose Aggravates Retinal Endothelial Cell Dysfunction by Activating the RhoA\/ROCK1\/pMLC\/Connexin43 Signaling Pathway. Investig Ophthalmol Vis Sci. 2022;63(8):22.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"4819_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13062-024-00498-7","volume":"19","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Tian M, Cao Y, Tang M, Xiang X, Guo L, et al. YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6. Biol Direct. 2024;19(1):54.","journal-title":"Biol Direct"},{"issue":"15","key":"4819_CR26","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.18632\/aging.204215","volume":"14","author":"C Ma","year":"2022","unstructured":"Ma C, Shi ZH, Han XY, Liu C, Yan B, Du JL. Targeting circRNA-MAP4K2 for the treatment of diabetes-induced retinal vascular dysfunction. Aging. 2022;14(15):6255\u201368.","journal-title":"Aging"},{"key":"4819_CR27","doi-asserted-by":"crossref","unstructured":"Wu R, Huang S, Xie JF, Wen NL, Wen M, Zhong SE. CircRNA SCAR improves high-glucose-induced mitochondrial dysfunction and permeability damage in retinal microvascular endothelial cells. Horm Metab Res. 2023;55(8):555\u201362.","DOI":"10.1055\/a-2108-9820"},{"key":"4819_CR28","doi-asserted-by":"crossref","unstructured":"Ma B, Wang S, Wu W, Shan P, Chen Y, Meng J, et al. Mechanisms of circRNA\/lncRNA\u2013miRNA interactions and applications in disease and drug research. Biomed Pharmacother. 2023;162:114672.","DOI":"10.1016\/j.biopha.2023.114672"},{"issue":"18","key":"4819_CR29","first-page":"5994","volume":"22","author":"JR Zhang","year":"2018","unstructured":"Zhang JR, Zhu RH, Han XP. MiR-140-5p inhibits larynx carcinoma invasion and angiogenesis by targeting VEGF-A. Eur Rev Med Pharmacol Sci. 2018;22(18):5994\u20136001.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"4819_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00011-019-01294-0","volume":"69","author":"Y Wang","year":"2020","unstructured":"Wang Y, Shen S, Li Z, Li W, Weng X. MIR-140-5p affects chondrocyte proliferation, apoptosis, and inflammation by targeting HMGB1 in osteoarthritis. Inflamm research: official J Eur Histamine Res Soc [et al]. 2020;69(1):63\u201373.","journal-title":"Inflamm research: official J Eur Histamine Res Soc [et al]"},{"issue":"2","key":"4819_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1871530315666150316121956","volume":"15","author":"M Shibuya","year":"2015","unstructured":"Shibuya M. VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases. Endocr Metab Immune Disord Drug Targets. 2015;15(2):135\u201344.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"4819_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","volume":"54","author":"A Arrigo","year":"2022","unstructured":"Arrigo A, Aragona E, Bandello F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy. Ann Med. 2022;54(1):1089\u2013111.","journal-title":"Ann Med"},{"issue":"11","key":"4819_CR33","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00417-020-04797-3","volume":"258","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu A, Zhang H, Wang M, Tang Q, Huang Y, et al. Inhibition of retinal neovascularization by VEGF siRNA delivered via bioreducible lipid-like nanoparticles. Graefe\u2019s archive Clin experimental Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2020;258(11):2407\u201318.","journal-title":"Graefe\u2019s archive Clin experimental Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04819-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04819-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04819-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:37:02Z","timestamp":1780439822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04819-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4819"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04819-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Chengdu AIDI Eye Hospital before the study began. The written informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}